Vaso sells VasoHealthcare IT to Nano-X for up to $800K; <5% of total revenue

VASO Corp

Sale consideration up to $800K: $200K at closing, $600K earnout tied to post-close performance.
VasoHealthcare IT represented less than 5% of Vaso's total revenue; proceeds to fund other business lines.
Transaction expected to close within weeks; Vaso engaged Barley Snyder as legal counsel.
Divestiture follows strategic review; CEO cites sharper focus on core operations as reason.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.